Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 57 results.
User Information
Export Records
  1. 1.   Sequencing-based functional assays for classification of BRCA2 variants in mouse ESCs
  2. Biswas,Kajal; Mitrophanov,Alex; Sahu,Sounak; Sullivan,Teresa; Southon,Eileen; Nousome,Darryl; Reid, Susan; Narula, Sakshi; Smolen, Julia; Sengupta, Trisha; Riedel-Topper, Maximilian; Kapoor, Medha; Babbar, Anav; Stauffer,Stacey; Cleveland, Linda; Tandon, Mayank; Malys,Tyler; Sharan,Shyam
  3. Cell Reports Methods. 2023, Nov 20; 3(11): 100628.
  1. 2.   Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma
  2. Xia, Bing; Biswas,Kajal; Foo, Tzeh Keong; Torres, Thiago; Riedel-Topper, Maximilian; Southon,Eileen; Kang, Zhihua; Huo, Yanying; Reid,Susan; Stauffer,Stacey; Zhou,Weiyin; Zhu, Bin; Koka, Hela; Yepes, Sally; Brodie, Seth A; Jones,Kristine; Vogt,Aurelie; Zhu,Bin; Cater, Brian; Freedman, Neal D; Hicks,Belynda; Yeager, Meredith; Chanock, Stephen J; Couch, Fergus; Parry, Dilys M; Monteiro, Alvaro N; Goldstein, Alisa M; Carvalho, Marcelo A; Sharan,Shyam; Yang, Xiaohong R
  3. Human Mutation. 2022, Jun 28;
  1. 3.   A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer
  2. Manzo, Julia; Puhalla, Shannon; Pahuja, Shalu; Ding, Fei; Lin, Yan; Appleman, Leonard; Tawbi, Hussein; Stoller, Ronald; Lee, James J; Diergaarde, Brenda; Kiesel, Brian F; Yu, Jing; Tan, Antoinette R; Belani, Chandra P; Chew, Helen; Garcia, Agustin A; Morgan, Robert J; Wahner Hendrickson, Andrea E; Visscher, Daniel W; Hurley, Rachel M; Kaufmann, Scott H; Swisher, Elizabeth M; Oesterreich, Steffi; Katz, Tiffany; Ji,Jay; Zhang, Yiping; Parchment, Ralph E; Chen, Alice; Duan, Wenrui; Giranda, Vincent; Shepherd, Stacie P; Ivy, S Percy; Chu, Edward; Beumer, Jan H
  3. Cancer Chemotherapy and Pharmacology. 2022, Apr 18; 89(5): 721-735.
  1. 4.   Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer
  2. Ren, Megan; Orozco, Anali; Shao, Kang; Albanez, Anaseidy; Ortiz, Jeremy; Cao, Boyang; Wang, Lusheng; Barreda, Lilian; Alvarez, Christian S.; Garland,Lisa; Wu,Dongjing; Chung,Charles; Wang,Jiahui; Frone, Megan; Ralon, Sergio; Argueta, Victor; Orozco, Roberto; Gharzouzi, Eduardo; Dean, Michael
  3. Breast cancer research and treatment. 2021, Jul 1;
  1. 5.   Epidemiological and ES cell-based Functional Evaluation of BRCA2 Variants Identified in Families with Breast Cancer
  2. O'Sullivan,Theresa; Thirthagiri, Eswary; Chong, Chan-Eng; Stauffer,Stacey; Reid,Susan; Southon,Eileen; Hassan, Tiara; Ravichandran, Aravind; Wijaya, Eldarina; Lim, Joanna; Taib, Nur Aishah Mohd; Fadzli, Farhana; Yip, Cheng Har; Hartman, Mikael; Li, Jingmei; van Dam, Rob M; North, Susan L; Das, Ranabir; Easton, Douglas F; Biswas,Kajal; Teo, Soo-Hwang; Sharan,Shyam
  3. Human Mutation. 2021, Feb; 42(2): 200-212.
  1. 6.   Exploring role of 5hmC as potential marker of chemoresistance
  2. Kharat,Suhas; Sharan,Shyam
  3. MOLECULAR & CELLULAR ONCOLOGY. 2020, Oct 22; 7(6): 1827904.
  1. 7.   Calcium-induced calcium release and type 3 ryanodine receptors modulate the slow afterhyperpolarising current, sI(AHP), and its potentiation in hippocampal pyramidal neurons
  2. Tedoldi, Angelo; Ludwig, Petra; Fulgenzi,Gianluca; Takeshima, Hiroshi; Pedarzani, Paola; Stocker, Martin
  3. PLOS ONE. 2020, JUN 19; 15(7):
  1. 8.   Functional evaluation of five BRCA2 unclassified variants identified in a Sri Lankan cohort with inherited cancer syndromes using a mouse embryonic stem cell-based assay
  2. Sirisena, Nirmala; Biswas,Kajal; Sullivan,Teresa; Stauffer,Stacey; Cleveland, Linda; Southon,Eileen; Dissanayake, Vajira H W; Sharan,Shyam
  3. Breast cancer research : BCR. 2020, May 11; 22(1): 43.
  1. 9.   RAD52 S346X Variant Reduces Breast Cancer Risk in BRCA2 Mutation Carriers
  2. Biswas,Kajal; Sharan,Shyam
  3. Molecular oncology. 2020, Apr 07;
  1. 10.   Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment
  2. Maniati, Eleni; Berlato, Chiara; Gopinathan, Ganga; Heath, Owen; Kotantaki, Panoraia; Lakhani, Anissa; McDermott, Jacqueline; Pegrum, Colin; Delaine-Smith, Robin M; Pearce, Oliver M T; Hirani, Priyanka; Joy, Joash D; Szabova,Ludmila; Perets, Ruth; Sansom, Owen J; Drapkin, Ronny; Bailey, Peter; Balkwill, Frances R
  3. Cell reports. 2020, Jan 14; 30(2): 525-540.e7.
  1. 11.   A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico
  2. Diaz-Zabala, Hector J; Ortiz, Ana P; Garland, Lisa; Jones, Kristine; Perez, Cynthia M; Mora, Edna; Arroyo, Nelly; Oleksyk, Taras K; Echenique, Miguel; Matta, Jaime L; Dean, Michael; Dutil, Julie
  3. Cancers. 2018, Nov 02; 10(11): pii: E419.
  1. 12.   Survival of BRCA2-Deficient Cells Is Promoted by GIPC3, a Novel Genetic Interactor of BRCA2
  2. Ding, Xia; Philip, Subha; Martin, Betty; Pang, Yan; Burkett, Sandra; Swing, Debbie; Pamala, Chinmayi; Ritt, Daniel A; Zhou, Ming; Morrison, Deborah; Ji, Xinhua; Sharan, Shyam
  3. Genetics. 2017, Dec; 207(4): 1335-1345.
  1. 13.   RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks.
  2. Dungrawala, Huzefa; Bhat, Kamakoti P; Le Meur, Rémy; Chazin, Walter J; Ding, Xia; Sharan, Shyam; Wessel, Sarah R; Sathe, Aditya A; Zhao, Runxiang; Cortez, David
  3. Molecular cell. 2017, Aug 3; 67(3): 374-+.
  1. 14.   Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.
  2. Ricks-Santi, Luisel; McDonald, J Tyson; Gold, Bert; Dean, Michael; Thompson, Nicole; Abbas, Muneer; Wilson, Bradford; Kanaan, Yasmine; Naab, Tammey J; Dunston, Georgia
  3. Ethnicity & disease. 2017, Apr 20; 27(2): 169-178.
  1. 15.   SERPINB3 and B4: From biochemistry to biology
  2. Sun, Y.; Sheshadri, Namratha; Zong, W. X.
  3. Seminars in Cell & Developmental Biology. 2017, Feb; 62: 170-177.
  1. 16.   Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells
  2. Reshma, R. S.; Sreelatha, K. H.; Somasundaram, V.; Satheesh Kumar, S.; Nadhan, R.; Nair, R. S.; Srinivas, P.
  3. Pharmacological Research. 2016, Mar; 105: 134-45.
  1. 17.   Advances in using PARP inhibitors to treat cancer
  2. Kummar, S.; Chen, A.; Parchment, R. E.; Kinders, R. J.; Ji, J.; Tomaszewski, J. E.; Doroshow, J. H.
  3. Bmc Medicine. 2012, Mar; 10
  1. 18.   Genetic deletion of trkB.T1 increases neuromuscular function
  2. Dorsey, S. G.; Lovering, R. M.; Renn, C. L.; Leitch, C. C.; Liu, X. Y.; Tallon, L. J.; Sadzewicz, L. D.; Pratap, A.; Ott, S.; Sengamalay, N.; Jones, K. M.; Barrick, C.; Fulgenzi, G.; Becker, J.; Voelker, K.; Talmadge, R.; Harvey, B. K.; Wyatt, R. M.; Vernon-Pitts, E.; Zhang, C.; Shokat, K.; Fraser-Liggett, C.; Balice-Gordon, R. J.; Tessarollo, L.; Ward, C. W.
  3. American Journal of Physiology-Cell Physiology. 2012, Jan; 302(1): C141-C153.
  1. 19.   A comprehensive functional characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based assay
  2. Biswas, K.; Das, R.; Alter, B. P.; Kuznetsov, S. G.; Stauffer, S.; North, S. L.; Burkett, S.; Brody, L. C.; Meyer, S.; Byrd, R. A.; Sharan, S. K.
  3. Blood. 2011, Sep; 118(9): 2430-2442.
  1. 20.   Rapid and Selective Nitroxyl (HNO) Trapping by Phosphines: Kinetics and New Aqueous Ligations for HNO Detection and Quantitation
  2. Reisz, J. A.; Zink, C. N.; King, S. B.
  3. Journal of the American Chemical Society. 2011, Aug; 133(30): 11675-11685.
  1. 21.   Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer
  2. Gaudet, M. M.; Kirchhoff, T.; Green, T.; Vijai, J.; Korn, J. M.; Guiducci, C.; Segre, A. V.; McGee, K.; McGuffog, L.; Kartsonaki, C.; Morrison, J.; Healey, S.; Sinilnikova, O. M.; Stoppa-Lyonnet, D.; Mazoyer, S.; Gauthier-Villars, M.; Sobol, H.; Longy, M.; Frenay, M.; Hogervorst, F. B. L.; Rookus, M. A.; Collee, J. M.; Hoogerbrugge, N.; van Roozendaal, K. E. P.; Piedmonte, M.; Rubinstein, W.; Nerenstone, S.; Van Le, L.; Blank, S. V.; Caldes, T.; de la Hoya, M.; Nevanlinna, H.; Aittomaki, K.; Lazaro, C.; Blanco, I.; Arason, A.; Johannsson, O. T.; Barkardottir, R. B.; Devilee, P.; Olopade, O. I.; Neuhausen, S. L.; Wang, X. S.; Fredericksen, Z. S.; Peterlongo, P.; Manoukian, S.; Barile, M.; Viel, A.; Radice, P.; Phelan, C. M.; Narod, S.; Rennert, G.; Lejbkowicz, F.; Flugelman, A.; Andrulis, I. L.; Glendon, G.; Ozcelik, H.; Tol, A. E.; Montagna, M.; D'Andrea, E.; Friedman, E.; Laitman, Y.; Borg, A.; Beattie, M.; Ramus, S. J.; Domchek, S. M.; Nathanson, K. L.; Rebbeck, T.; Spurdle, A. B.; Chen, X. Q.; Holl, H.; John, E. M.; Hopper, J. L.; Buys, S. S.; Daly, M. B.; Southey, M. C.; Terry, M. B.; Tung, N.; Hansen, T. V. O.; Nielsen, F. C.; Greene, M. I.; Mai, P. L.; Osorio, A.; Duran, M.; Andres, R.; Benitez, J.; Weitzel, J. N.; Garber, J.; Hamann, U.; Peock, S.; Cook, M.; Oliver, C.; Frost, D.; Platte, R.; Evans, D. G.; Lalloo, F.; Eeles, R.; Izatt, L.; Walker, L.; Eason, J.; Barwell, J.; Godwin, A. K.; Schmutzler, R. K.; Wappenschmidt, B.; Engert, S.; Arnold, N.; Gadzicki, D.; Dean, M.; Gold, B.; Klein, R. J.; Couch, F. J.; Chenevix-Trench, G.; Easton, D. F.; Daly, M. J.; Antoniou, A. C.; Altshuler, D. M.; Offit, K.; kConFab, G. S. C. H. S. C. O.
  3. Plos Genetics. 2010, Oct; 6(10): 12.
  1. 22.   Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan)
  2. Jacobs, E. J.; Chanock, S. J.; Fuchs, C. S.; LaCroix, A.; McWilliams, R. R.; Steplowski, E.; Stolzenberg-Solomon, R. Z.; Arslan, A. A.; Bueno-de-Mesquita, H. B.; Gross, M.; Helzlsouer, K.; Petersen, G.; Zheng, W.; Agalliu, I.; Allen, N. E.; Amundadottir, L.; Boutron-Ruault, M. C.; Buring, J. E.; Canzian, F.; Clipp, S.; Dorronsoro, M.; Gaziano, J. M.; Giovannucci, E. L.; Hankinson, S. E.; Hartge, P.; Hoover, R. N.; Hunter, D. J.; Jacobs, K. B.; Jenab, M.; Kraft, P.; Kooperberg, C.; Lynch, S. M.; Sund, M.; Mendelsohn, J. B.; Mouw, T.; Newton, C. C.; Overvad, K.; Palli, D.; Peeters, P. H. M.; Rajkovic, A.; Shu, X. O.; Thomas, G.; Tobias, G. S.; Trichopoulos, D.; Virtamo, J.; Wactawski-Wende, J.; Wolpin, B. M.; Yu, K.; Zeleniuch-Jacquotte, A.
  3. International Journal of Cancer. 2010, Sep; 127(6): 1421-1428.
  1. 23.   Functional analysis of human BRCA2 variants using a mouse embryonic stem cell-based assay
  2. Kuznetsov, S. G.; Chang, S.; Sharan, S. K.
  3. Methods in molecular biology (Clifton, N.J.). 2010 653: 259-80.
  1. 24.   Expression of human BRCA1 variants in mouse ES cells allows functional analysis of BRCA1 mutations
  2. Chang, S.; Biswas, K.; Martin, B. K.; Stauffer, S.; Sharan, S. K.
  3. Journal of Clinical Investigation. 2009, Oct; 119(10): 3160-71.
  1. 25.   The Hypervariable Region of K-Ras4B Is Responsible for Its Specific Interactions with Calmodulin
  2. Abraham, S. J.; Nolet, R. P.; Calvert, R. J.; Anderson, L. M.; Gaponenko, V.
  3. Biochemistry. 2009 48(32): 7575-7583.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel